When auditing a CJC-1295 DAC COA or evaluating CJC-1295 No DAC purity, PX1 Research provides batch-matched third-party analytical testing for every lot. Our USA-manufactured growth-hormone-releasing hormone (GHRH) analogs undergo RP-HPLC purity validation (>99%), ESI-MS mass spectrometry identity verification, and USP <85> endotoxin testing. Orders ship same-day M–F from California and Arizona fulfillment centers.
When auditing a CJC-1295 DAC COA or evaluating CJC-1295 No DAC purity, PX1 Research provides batch-matched third-party analytical testing for every lot. Our USA-manufactured growth-hormone-releasing hormone (GHRH) analogs undergo RP-HPLC purity validation (>99%), ESI-MS mass spectrometry identity verification, and USP <85> endotoxin testing. Orders ship same-day M–F from California and Arizona fulfillment centers.
A Certificate of Analysis (COA) is the primary documentation required to verify the chemical integrity, identity, and purity of synthesized peptides before conducting in vitro or preclinical experiments. For GHRH analogs like CJC-1295 (with or without DAC), relying on unverified purity claims compromises experimental reproducibility.
A compliant CJC-1295 DAC COA must include reverse-phase high-performance liquid chromatography (RP-HPLC) chromatograms to quantify purity, electrospray ionization mass spectrometry (ESI-MS) spectrum data to confirm exact molecular weight, and chromogenic LAL assays to ensure endotoxin safety. PX1 Research publishes lot-specific analytical reports accessible directly on our research peptides documentation hub.
Key takeaways for lab managers evaluating CJC-1295 documentation:
• Chromatographic purity must meet or exceed 99.0% with clearly resolved target peak areas.
• Observed molecular mass on MS must match theoretical molecular mass within ±1 Da.
• Endotoxin levels should be verified under <0.01 EU/mg to eliminate confounding cellular inflammation.
• Batch numbers on physical vials must correspond exactly to the published third-party test report.
CJC-1295 is a synthetic 29-amino-acid peptide derivative of endogenous growth-hormone-releasing hormone (GHRH 1-29). In preclinical literature, CJC-1295 functions as a selective GHRH receptor agonist, stimulating the anterior pituitary gland to release growth hormone (GH) in a pulsatile manner, which subsequently elevates downstream insulin-like growth factor 1 (IGF-1) concentrations. Researchers utilize these mechanisms to investigate tissue repair, protein synthesis, and metabolic regulation in cell cultures and animal models.
The primary distinction within this compound class lies in the presence of the Drug Affinity Complex (DAC). CJC-1295 with DAC incorporates a reactive maleimido derivative attached to the Lys27 residue. In living biological systems, this moiety covalently binds to circulating serum albumin, extending the peptide's elimination half-life from approximately 30 minutes to over 6–8 days. Conversely, CJC-1295 No DAC (also known as Mod GRF 1-29) lacks this complex, yielding rapid clearance ideal for acute GH surge research. You can inspect the structural specifications and lab-grade formats by reviewing CJC-1295 No DAC 5 mg vials in our catalog.
Whether examining systemic half-life extension via DAC modification or rapid receptor kinetics using unmodified analogs, high-purity raw material is non-negotiable. Contaminants such as truncated sequences or deletion peptides alter binding affinity and distort quantitative receptor binding studies.
A legitimate CJC-1295 COA presents raw, unedited data from an accredited independent laboratory. When reviewing documentation for research-grade materials, researchers should systematically analyze four distinct testing protocols:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): RP-HPLC separates the primary peptide sequence from synthesis byproducts, truncated fragments, and protecting group adducts. The resulting chromatogram displays peak retention times. Purity is calculated as the integration area of the main peptide peak relative to total peak areas. High-purity CJC-1295 yields a single sharp main peak exceeding 99.0% area representation.
2. Mass Spectrometry (ESI-MS / MALDI-TOF): While HPLC confirms purity, MS confirms identity. Mass spectrometry measures the mass-to-charge ratio (m/z) of the molecule. The theoretical molecular weight of CJC-1295 No DAC is approximately 3367.9 Da, whereas CJC-1295 DAC possesses a higher molecular weight (approx. 3647.2 Da) due to the maleimide linker. The observed peak must align precisely with theoretical calculations.
3. Endotoxin Assay (USP <85>): Bacterial endotoxins (lipopolysaccharides) from Gram-negative bacteria can induce severe inflammatory reactions in biological assays. COAs should confirm endotoxin levels below 0.05 EU/mg (and ideally <0.01 EU/mg), ensuring cell viability in delicate culture media.
4. Net Peptide Content & Water Analysis: Lyophilized peptides contain residual moisture and counterions (such as trifluoroacetate salts). A complete certificate specifies peptide content via amino acid analysis (AAA) or CHN elemental analysis, differentiating total powder weight from active peptide mass.
In commercial peptide chemistry, the claim '99% purity' is frequently used as a marketing buzzword, but its technical meaning is specific to chromatographic peak integration. RP-HPLC purity reflects the absence of structural peptide impurities—such as diastereomers, deletion sequences missing single amino acid residues, or oxidized side chains.
However, 99% chromatographic purity does not mean a 10 mg vial contains 9.9 mg of pure peptide by weight. Solid-phase peptide synthesis (SPPS) requires trifluoroacetic acid (TFA) during cleavage and purification. Consequently, final lyophilized cakes consist of target peptide molecules, TFA counterions, and trace residual moisture. The actual peptide content typically ranges between 80% and 90% of the total dry powder weight, with the remainder composed of neutral salts and water.
To maintain rigors in quantitative research, investigators must account for net peptide content when calculating molar concentrations for in vitro assays. PX1 Research provides clear batch details across our entire inventory, allowing researchers to buy research peptides online backed by fully transparent analytical documentation.
Not all research chemical vendors apply the same quality controls. Below is a structured comparison outlining the analytical rigor and operational criteria applied by PX1 Research compared to typical online suppliers:
Ensuring data integrity in experimental models requires rigorous supplier vetting. When examining vendor documentation, laboratory managers should watch for several warning signs that indicate unreliable quality control:
• Missing Raw HPLC/MS Graphs: A text-only summary sheet stating '99% pure' without attached chromatograms or mass spectrum charts is invalid. Authentic COAs display complete axis scaling, baseline resolution, and peak table calculations.
• Mismatched Molecular Weights: If a supplier lists CJC-1295 DAC but provides a mass spectrum matching unmodified CJC-1295 (Mod GRF 1-29) at ~3367 Da, the product lacks the Drug Affinity Complex extension.
• Obfuscated Laboratory Information: Third-party testing reports should clearly name the independent analytical testing laboratory, report date, sample ID, and testing methodology.
• Generic or Non-Lot-Specific COAs: Displaying a single high-purity COA on a product page without updating batch numbers across different manufacturing runs is a primary sign of insufficient quality management.
Researchers seeking fully verified GHRH analogs can review analytical specifications for CJC-1295 No DAC high purity vials directly within our catalog.
Maintaining sequence stability and biological activity requires proper reconstitution and storage protocols upon arrival at the laboratory facility.
Lyophilized CJC-1295 powders should be stored at -20°C for short-term preservation or -80°C for long-term storage, protected from light and moisture ingress. Prior to reconstitution, vials should be allowed to equilibrate to room temperature to prevent condensation formation inside the container.
Reconstitution is typically performed using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile normal saline, depending on assay requirements. Solvent should be introduced slowly down the interior glass wall of the vial, followed by gentle swirling. Mechanical agitation or vigorous shaking must be avoided, as shear forces can disrupt peptide tertiary structure or cause aggregation. Once reconstituted, liquid aliquots should be maintained at 2°C to 8°C and used within defined experimental windows to prevent hydrolytic degradation. For comparative structural studies involving complementary secretagogues, researchers frequently evaluate Ipamorelin 5 mg vials alongside GHRH analogs.
In neuroendocrine research, GHRH analogs are frequently studied in combination with Growth Hormone Releasing Peptides (GHRPs) to analyze synergistic receptor activation patterns. While GHRH analogs like CJC-1295 act on the GHRH receptor via the cAMP/PKA signal transduction pathway, GHRPs target the growth hormone secretagogue receptor (GHSR-1a) via intracellular calcium mobilization.
Combining GHRH analogs with selective GHSR agonists (such as Ipamorelin) produces a synergistic release of growth hormone in pituitary cell assays that significantly exceeds the additive response of either peptide alone. Researchers examining these dual-pathway mechanisms can explore detailed chemical profiles in our article covering CJC-1295 vs Ipamorelin research protocols.
To support broad-scale comparative research projects, PX1 Research maintains full batch documentation for all complementary peptides available across our complete research peptide inventory.
PX1 Research is engineered to support university laboratories, biotechnology institutes, and independent research facilities that demand uncompromising analytical purity and reliable supply chains. When placing an order with PX1 Research, laboratory managers receive fully characterized, USA-manufactured compounds backed by lot-specific documentation.
Orders placed before 3:00 PM PST Monday through Friday ship same-day from our strategically located California and Arizona logistics nodes. Every shipment features temperature-controlled packaging options, discrete protective wrapping, and full tracking updates from dispatch to laboratory delivery.
Every vial contains lyophilized powder prepared in controlled environments to eliminate cross-contamination. Whether securing small batch evaluations or setting up recurring research requisitions, our team offers dedicated responsive support to assist with technical specifications and COA verification. Investigators requiring larger batch volumes for extended studies can also submit inquiries through our wholesale peptide supply channel.
Secure your laboratory requirements today: inspect our third-party testing metrics and order CJC-1295 No DAC vials directly from PX1 Research.
cjc-1295 dac coa: What specific data should it contain?
A compliant CJC-1295 DAC COA must include an RP-HPLC chromatogram verifying purity above 99.0%, an ESI-MS mass spectrum matching the theoretical molecular weight of ~3647.2 Da, and a chromogenic LAL assay showing endotoxins below 0.05 EU/mg. It must also list explicit batch numbers matching the physical product label.
cjc-1295 coa: How do I verify the authenticity of my lot test report?
You can verify a CJC-1295 COA by cross-referencing the physical batch lot number printed on your PX1 Research vial label with the downloadable PDF on our documentation portal. Each COA is generated by an accredited third-party laboratory with verifiable analytical equipment calibration logs.
What is the molecular weight difference between CJC-1295 DAC and CJC-1295 No DAC on a COA?
On mass spectrometry analysis, CJC-1295 No DAC (Mod GRF 1-29) exhibits a molecular weight of approximately 3367.9 Da. CJC-1295 with DAC includes the Drug Affinity Complex maleimide structure, increasing its molecular weight to approximately 3647.2 Da. A COA confirms which specific variant is present.
Why is endotoxin testing critical on a CJC-1295 DAC COA?
Bacterial endotoxins can trigger immune responses and cellular toxicity in in vitro assays, invalidating research data. Verifying endotoxin levels under <0.01 EU/mg on a COA ensures that observed biological responses stem strictly from GHRH receptor stimulation rather than inflammatory contamination.
What purity level is required for CJC-1295 laboratory research?
In vitro and preclinical research protocols require a minimum of 98.0% purity, though >99.0% is preferred. High chromatographic purity prevents receptor binding interference from truncated peptide fragments or cleavage impurities generated during solid-phase synthesis.
How does RP-HPLC measure CJC-1295 purity?
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) separates compounds based on hydrophobicity as they pass through a stationary phase column. Purity is calculated by dividing the integrated peak area of the target CJC-1295 molecule by the total area of all detected peaks.
Is CJC-1295 legal to buy for research purposes in the USA?
Yes, CJC-1295 (both DAC and No DAC variants) is legal to purchase in the United States strictly as a non-clinical research chemical intended for laboratory in vitro and animal research. It is not approved for human consumption, clinical use, or veterinary administration.
How fast does PX1 Research ship CJC-1295 orders?
PX1 Research dispatches orders same-day Monday through Friday when placed before 3:00 PM PST. Shipments originate from fulfillment facilities in California and Arizona, providing fast domestic transit with full tracking visibility.
How should reconstituted CJC-1295 be stored in the laboratory?
Reconstituted CJC-1295 solutions should be stored in sterile, airtight glass vials at 2°C to 8°C for short-term use (up to 30 days). For extended experimental timelines, reconstituted aliquots should be stored at -20°C or -80°C to prevent hydrolysis.
Can bulk buyers request custom lot COAs for wholesale orders?
Yes. Institutional buyers placing volume orders through the PX1 Research wholesale portal receive batch-matched third-party COAs for every lot, ensuring consistent purity, mass verification, and low endotoxin counts across large supply runs.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.